课题基金 / 基金详情

Research for the anti-thrombus and anti-inflammation of annexin-V

Research for the anti-thrombus and anti-inflammation of annexin-V
annexin-V抗血栓和抗炎作用的研究
批准号:
04671359
负责人:
FUNAKOSHI Takayuki
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

FUNAKOSHI Takayuki的其他基金

相似基金

相关文献

中文摘要
翻译
胎盘抗凝蛋白- i (PAP-I, T.Funakoshi et al., Biochemistry 26,5572(1987))是从人胎盘中纯化出来的Ca^<2+>依赖性磷脂结合蛋白的膜联蛋白家族成员。蛋白质和cDNA序列数据显示,pap - 1、II、III和IV分别对应于annexin-V、IV、III和II (M.J.Crumpton和j.r.d dedman, Nature 345, 212(1990))。Annexin-V是这些蛋白中最丰富的,由319个氨基酸组成,每个氨基酸含有70-90个氨基酸的四个串联重复序列(T.Funakoshi et al., Biochemistry 26,8087(1987))。膜联蛋白v抑制血液凝固的外在和内在途径,并在Ca^<2+>存在下特异性结合阴离子磷脂表面。膜联蛋白v也抑制磷脂酶A2对磷脂的水解。这种抑制作用被认为可以抑制前列腺素的合成,从而起到抗炎作用。肽SHLRKV和DHTLIR,分别对应于膜联蛋白v残基204-209和266-271,包含在膜联蛋白v的功能位点,并表现出有效的抗凝血活性,而丙氨酸取代组氨酸的肽则没有。此时,我们合成了这两种肽以及HDTLIR和HDTQPRVLD两种肽,以确定这些肽的结构和功能关系。这些肽和膜联蛋白- v分别降低了小鼠肺栓塞的死亡率。
英文摘要
Placental anticoagulant protein-I(PAP-I, T.Funakoshi et al., Biochemistry 26,5572(1987), purified from human placenta, is a member of annexin family of Ca^<2+>-dependent phospholipid binding proteins. Protein and cDNA sequence data show that PAP-I, II, III and IV correspond to annexin-V, IV, III and II, respectively (M.J.Crumpton and J.R.Dedman, Nature 345, 212(1990)). Annexin-V, the most abundant of these proteins, is composed of 319 amino acids containing four tandem repeats of 70-90 amino acid each (T.Funakoshi et al., Biochemistry 26,8087(1987)). Annexin-V inhibit the extrinsic and intrinsic pathways of blood coagulation and binds specifically to anionic phospholipid surfaces in the presence of Ca^<2+>. Annexin-V also inhibits the hydrolysis of phospholipid by phospholipase A2. This inhibition is thought to suppress prostaglandin synthesis leading to antiinflammatory action.The peptides, SHLRKV and DHTLIR, corresponding to annexin-V residues 204-209 and 266-271, respectively, are included in the functional site of annexin-V and exhibit a potent anticoagulant activity but the peptides in which alanine is substituted for histidine do not. At this time, we synthesized the both peptides and the other peptides, HDTLIR and HDTQPRVLD, to determine the relationship of the structures and function of these peptides. These peptides and annexin-V lowered the death rates of the pulmonary embolism in mice, respectively.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Takayuki Funakoshi, Hideaki Shimada, Shoji Kojima et al.: "Anticoagulant Action of Vanadate" Chem.Pharm.Bull.40. 174-176 (1992)
Takayuki Funakoshi、Hideaki Shimada、Shoji Kojima 等人:“钒酸盐的抗凝作用”Chem.Pharm.Bull.40。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
古島浩二、船越崇行、島田秀昭、児島昭次: "ヒト胎盤由来抗凝固蛋白質(Annexin-V)に対する希土類金属の影響" 生化学. 64. 1003 (1992)
Koji Furushima、Takayuki Funakoshi、Hideaki Shimada、Shoji Kojima:“稀土金属对人胎盘来源的抗凝蛋白(Annexin-V)的影响”生物化学 64. 1003 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
船越崇行、島田秀昭、児島昭次他5名: "Anticoagulant Action of Vanadate" Chem.Pharm.Bull.40. 174-176 (1992)
Takayuki Funakoshi、Hideaki Shimada、Shoji Kojima 和其他 5 人:“钒酸盐的抗凝作用”Chem.Pharm.Bull.40 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
坂田光彦、真鍋史朗、折田正義、高宮修、船越崇行: "胎盤由来抗凝固蛋白質(PAP-I,Annexin-V)の疾患との関連" 臨床病理(Jpn.J.Clin.Pathol.). 41. 328 (1993)
Mitsuhiko Sakata、Shiro Manabe、Masayoshi Orita、Osamu Takamiya、Takayuki Funakoshi:“胎盘来源的抗凝蛋白(PAP-I、Annexin-V)与疾病的关系”临床病理学(Jpn. J. Clin. Pathol.)。 328 (1993)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    Effects of rare earth metals on blood coagulation and fiblinolysis
    • 批准号:
      08672517
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      FUNAKOSHI Takayuki
    • 依托单位:
    Structure and Function of Placental Anticoagulant Protein (PAP)
    • 批准号:
      01571219
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1989
    • 负责人:
      FUNAKOSHI Takayuki
    • 依托单位:
    海外基金